alexa Genetically Modified Medicago truncatula Lacking Calcium Oxalate has Increased Calcium Bioavailability and Partially Rescues Vitamin D Receptor Knockout Mice Phenotypes
ISSN: 0975-0851
Journal of Bioequivalence & Bioavailability

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Genetically Modified Medicago truncatula Lacking Calcium Oxalate has Increased Calcium Bioavailability and Partially Rescues Vitamin D Receptor Knockout Mice Phenotypes

Xiangkai Li1*, Jian Yang2, Jay Morris3, Ashley Hester2, Paul A. Nakata2 and Kendal D. Hirschi2,4

1Key Laboratory of Cell Activities and Stress Adaptations, School of Life Sciences, Lanzhou University, Lanzhou, Gansu, 730000, P. R. China

2United States Department of Agriculture/Agriculture Research Service, Children’s Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas 77030, USA

3Department of Molecular Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA

4Vegetable and Fruit Improvement Center, Texas A&M University, College Station, Texas 77845, USA

*Corresponding Author:
Xiangkai Li
School of Life Sciences, Lanzhou University
Tianshui Nan Lu #222, Lanzhou
Gansu, 730000, P. R. China
Tel: 86-931-8912561
Fax: 86-931-8912560
E-mail: [email protected]

Received Date: December 06, 2012; Accepted Date: December 21, 2012; Published Date: December 27, 2012

Citation: Li X, Yang J, Morris J, Hester A, Nakata PA, et al. (2013) Genetically Modified Medicago truncatula Lacking Calcium Oxalate has Increased Calcium Bioavailability and Partially Rescues Vitamin D Receptor Knockout Mice Phenotypes. J Bioequiv Availab 5: 047-052. doi: 10.4172/jbb.1000133

Copyright: © 2013 Li X, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Bioequivalence & Bioavailability


Background: How the distribution and sequestered form of plant macro/micro-nutrients influence their
bioavailability, and ultimately impact human health, are poorly understood. The legume Medicago truncatula has a portion of its tissue calcium (Ca) sequestered in the form of the Ca oxalate (CaOx) crystal which reduces its nutritional value in terms of Ca bioavailability. The calcium oxalate deficient 5 (cod5) mutant has a total Ca content similar to wild-type (WT) plants, but sequesters less of its tissue Ca in the form of the CaOx crystal. Previous short-term mice feeding studies suggest that this difference is responsible for the improved Ca bioavailability of the cod5
plants compared to WT plants.

Objectives: To perform long term feeding studies with Vitamin D Receptor Knockout (VDR-KO) mice and the
nutritionally improved cod5 line to assess the impact of increased Ca bioavailability on VDR-KO Ca deficiency phenotypes.

Methods: To assess the ability of diets containing cod5 plant material as the sole Ca source to rescue the Ca deficiency phenotypes of the VDR-KO mice we conducted both short term and long term experiments. Specifically, Ca absorption and utilization were measured short term (24-hour) in the hind limb bones and duodenum tissue of VDR-KO mice that were fed either an intrinsically 45Ca labeled cod5 or WT Medicago diet. Long term (20-day) bodyweight gain and change in Bone Mineral Density (BMD) were also measured over a 20 day period in VDR-KO mice fed either a cod5 or WT Medicago diet.

Results: In the 24-hour feeding study, 45Ca incorporation was found to be 46.3% (male) or 53.9% (female)
higher in hind limb bones (P<0.01); and 32.5% (male) or 38.5% (female) higher in duodenums (P<0.01) in VDR-KO mice fed cod5 than those fed WT plants. In the 20-day feeding study, the VDR-KO mice (male) fed cod5 gained 38.1% more bodyweight than those fed WT plants (P=0.06). The increase of BMD after 20 days in the VDR-KO mice (male) fed cod5 diets was 22.5% higher than those fed WT diets (P=0.17).

Conclusions: Our study confirms and extends an earlier study by showing that cod5 Medicago not only had
higher Ca bioavailability but it can also rescue, in part, the VDR-KO Ca deficiency phenotypes. Thus, the removal of CaOx from a plant-based diet appears to be a viable long-term dietary option to boost bioavailable Ca levels and help combat Ca related disorders.


Calcium bioavailability; Medicago trunculata; Vitamin D receptor knockout mice; Oxalate; Calcium Oxalate Deficient 5 (cod5)


Ca: Calcium; CaOx: Calcium Oxalate; WT: Wildtype; BMD: Body Mineral Density


Nutritional recommendations agree on the importance of a predominantly plant-based diet (; however, sole reliance on plants for nutrition can limit the intake of the essential nutrients calcium (Ca), vitamins B12 and D [1]. Bioavailable Ca is critical to human health, which is needed specifically for bone growth and muscle control. Inadequate Ca uptake can cause imbalanced Ca levels in serum, resulting in hormone-regulated adaptation which promotes the mobilization of Ca from bone Ca phosphate and increases the risk of osteoporosis [2,3]. In recent years, concerns over the development of osteoporosis in an aging population has led to an increase in food fortification of Ca in the United States [4,5]. Several studies show that Ca-fortified vegetables can increase Ca uptake in mice and humans [6,7], but the long term efficacy of these fortification activities remains questionable [8].

Calcium in plants exist as complexes with oxalate, phytate, and fiber [9,10], all of which suppress Ca bioavailability. It is believed that the Ca oxalate (CaOx) content is the best predictor of Ca availability [11]. For example, spinach contains a high concentration of Ca but a significant amount of this Ca is complexed with oxalate which reduces its Ca bioavailability to about 5.0% [12]. However, in soybeans oxalate levels are similar to spinach but its Ca bioavailability is around 20% [13]. This variation among plants warrants further investigation of how CaOx impacts bioavailability.

In humans, oxalate cannot be metabolized so after ingestion and absorption it is usually excreted. In some instances; however, the oxalate can complex with Ca before excretion occurs and result in the formation of kidney stones, particularly in those with low Ca intake [14,15]. Patients suffering from hyperoxaluria, a condition characterized by over-production of oxalate in the body leading to the development of kidney stones, are advised to avoid high-oxalate foods and to supplement with Ca [16]. Given the importance of adequate Ca for human health, and the potential negative health effects of excessive oxalate consumption for those with oxalate sensitivities, manipulation of CaOx formation is an important target of biofortification efforts, which aims to enhance the bioavailability of Ca and reduce oxalate content in food crops [17].

The low oxalate mutant from the model forage legume Medicago trunculata, calcium oxalate deficient 5 (cod5), has been previously identified [18]. The cod5 plant is devoid of prismatic crystals of CaOx. Growth studies and total mineral composition measurements indicate no substantial difference between cod5 and WT with the exception of oxalate crystal content [19]. The removal of crystalline oxalate in M. truculata results in increased Ca absorption in mice [6]. However, no long-term feeding studies have been carried out to evaluate the benefits of cod5 diets due to the lack of easy-to-monitor physiological phenotypes in normal mice fed with low Ca diets.

The Vitamin D Receptor (VDR) is a member of the superfamily of nuclear receptors which regulates gene expression in a ligand activated manner [20]. The hormonal metabolite of vitamin D, 1, 25-dihydroxyvitamin D3 (1, 25(OH)2D3) functions as the ligand for VDR [21-23]. VDR dependent transcellular Ca absorption is important in maintaining Ca homeostasis when Ca concentrations are low [22]. The VDR knockout (VDR-KO) mice exhibit decreased serum Ca levels, reduced duodenal Ca absorption, impaired bone formation and growth retardation on 0.5% Ca diet [22,24,25]. However, on an excessive 2% Ca diet, the serum Ca balance, duodenal Ca intake, bone growth and body weight gain in VDR-KO mice can be partially restored, likely through a VDR independent system [24-26]. Therefore the enhanced sensitivity to dietary Ca levels of VDR-KO mice makes them ideal models to test the bioequivalence and bioavailability of Ca in cod5 lines during long term feeding regimes.

In our study, we used VDR-KO mice to test the bioavailability of Ca in cod5 and WT Medicago leaf tissue to evaluate the long-term impacts of a cod5 based diet. Our results demonstrate the longitudinal impacts of reduced CaOx content in plant diets in animals with defects in Ca metabolism.

Materials and Methods

Plant growth and preparations

Medicago truncatula WT (cv. Jemalong, ecotype A17) and cod5 seeds were nicked with a razor blade and allowed to germinate on agar plates. The germinated plants were then grown hydroponically for 30 days before the leaves were cut back [27]. To intrinsically label WT and cod5 Medicago with 45Ca, the hydroponic solution was supplemented with 1 μCi 45Ca/L after the removal of the leaves and grown for 30 additional days. Then the leaves were harvested and processed as described previously [6]. In brief, leaves were harvested and freeze dried [18,28], and then the material was frozen in liquid nitrogen and ground to a powder with a mortar and pestle [6].

Determination of bulk Ca and oxalate concentration

Calcium concentration measurements were carried out using inductively coupled plasma atomic emission absorption spectrometry on weighed leaf samples (Soil, Water and Forage Testing Laboratory, Texas A&M University). Each measurement was done in duplicate on three independently grown sets of plants. The results were averaged with standard error calculated [28].

Oxalate measurements were conducted as previously described [18]. In brief, weighed freeze-dried leaf samples were ground in water and centrifuged. The supernatant was decanted and the soluble oxalate measured using an oxalate diagnostic kit (Trinity Biotech 591-D). The amount of total oxalate was determined by simply omitting the centrifugation step and solubilizing the Ca oxalate crystals through the addition of H+-Dowex in dilute acid. The mixture was heated at 60°C for 1 hour, and the pH of the mixture was adjusted to between 5 and 7. The mixture then was charcoal filtered and centrifuged. The supernatant was then analyzed for oxalate content using the oxalate diagnostic kit (Trinity Biotech). Measurements were done in triplicate on three independently grown sets of plants.

Diet preparation and mice genotyping

Calcium limited AIN-93G diets were (Ca concentration 0.5%) obtained from Research Diets (New Brunswick, NJ). To obtain various diets with low (0.5%) or high Ca (2%) levels, Ca limited AIN-93G diets were mixed with freeze-dried WT, or cod5 plants, or other Ca chemicals (CaCl2, or CaC2O4 (CaOx)) (Table 1). 3.5 g of these diets were calorically and nutritionally equivalent (except for Ca) to the standard AIN-93G diet [26]. Animal protocols were approved by the Baylor College of Medicine Institutional Animal Care and Use Committee [29]. VDRKO mice were generated by breeding heterozygous mice. At the age of ten days, tail clips were taken for genotyping. Genotyping Primers used were: Forward 5’-TTTGGATCCATGGAGGCAATGCAGCCAGC -3’,

Diet name Ca Source Weight of Ca Source (g) Modified Low Ca2+ AIN diets (g) Ca Content (%) Kcal / kg
Low Ca N/A 0 1000 0.5% 3670
2% Ca CaCl2 9.7 990.3 2% 3633
CaOx CaC2O4 11.2 988.8 2% 3630
WT WT Medicago 233 767 2% 3515
cod5 cod5 Medicago 233 767 2% 3515

Table 1: The ingredients, calcium and calorie composition in five diets used in the 20-day feeding study (per total weight of 1000 g).

Reverse 5 ’-T T T G G T A C C T CA G G A G A T C T C A T T G C C A A A C A C C T C -3’,


On day 21 postpartum, confirmed VDR-KO mice or WT mice were weaned and assigned to the experiments based on their genotype and gender. Throughout the experiments, mice were housed in cages with ad libitum access to water and food prior to the initiation of the experiment. Before the feeding experiments, mice were maintained on AIN-93G diet that contains 2% Ca [6].

Measurement of Ca absorption in hind limbs and duodenum

The VDR-KO mice were stratified and deprived of food for 24 hours and separated into two treatment groups (n=12 per group, six males and six females) using a randomized block design. After the 24 hours fasting, 3.5 g of each diet (Table 1) was placed in a glass food jar and placed into the cage. The amount of diet fed to each mouse represented 14.0 kcal. The small serving size of diets also insured that the mice ate the majority of the test meal over the allotted 24 hours. All mice were euthanized in CO2 chamber after 24 hours of feeding and placed at 4°C for 24 hours. The bones of the two hind limbs (femur, tibia, and fibula) were removed to measure bone Ca absorption. The soft tissue was surgically removed with a scalpel and the bones were then ashed to remove all the organic matter. The ashing was performed in a muffle furnace (Thermolyne Furnace, Barnsted International, Dubuque, IW) at 700°C for 30 hours. The duodenum was removed with a scalpel to measure duodenal Ca absorption. The tissue was collected in 1 ml PBS buffer and sonicated to homogenization. The amount of 45Ca incorporated in the sample was determined by a scintillation counter.

Long term feeding study and measurement of bone mineral density (BMD)

In the pilot study, male VDR-KO mice demonstrated higher sensitivity to Ca intake (data not shown), so we chose male VDRKO mice for long term feeding study. Ten or twenty (depending on the diet groups) male weaning VDR-KO mice were allotted into one of five different diets (Table 1) using a randomized block design [7]. 3.5 g of each diet was placed in a glass food dish and placed into the cage every day for 20 days. Water was allowed ad libitum throughout the experiment. Individual bodyweight was recorded every 24 hours. The BMD of the VDR-KO mice were measured by Dual Energy X-ray Absorptiometry (DEXA; PIXImus instrument, Lunar Corp., Madison, WI) on Day 1 and Day 20 for ten mice in each diet group. The precision was ± 1% coefficient of variation in vitro. DEXA test was taken on each mouse at the start and the end of the experiment to determine the bone mineral contents. The tests were carried out as previously described [30,31].

Data analysis

The statistical analysis was performed using SPSS Version 11. T-test among five groups was conducted and subsequent pairwise comparisons were performed with Sidak multiple comparison test.


Previously, we showed that cod5 diets display increased Ca bioavailability [6]. However, we have not demonstrated if this dietary change can impact animal growth and development. Here, we first tested 45Ca incorporation into VDR-KO mice hind limbs and the duodenum. In a 24-hour feeding study, the VDR-KO mice fed 45Calabeled cod5 diets had 7.80 ± 0.51% (Male)/7.48 ± 0.91% (Female) hind limb bone Ca incorporation while VDR-KO mice fed 45Ca labeled WT Medicago diets had 5.33 ± 0.46% (Male)/4.86 ± 0.77% (Female) hind limb bone Ca incorporation (Figure 1A). For duodenal Ca absorption, the VDR-KO mice fed 45Ca labeled cod5 Medicago had 0.57 ± 0.09% (Male)/0.54 ± 0.12% (Female) duodenal Ca incorporation while VDRKO mice fed 45Ca labeled WT diets had 0.43 ± 0.07% (Male)/0.39 ± 0.05% (Female) duodenal Ca incorporation (Figure 1B). The group fed the cod5 diet displayed 46.3% (male)/53.9% (female) higher Ca absorption in hind limb bones (P<0.01) and 32.5% (male)/38.5% (female) higher Ca absorption in duodenums (P<0.01) than the group fed the WT diet.


Figure 1: Hind limb bone and duodenal 45Ca incorporation in VDR-KO mice fed wild-type (?) or cod5 (?) Medicago diet.
A, Incorporation rate of 45Ca per 1 gram of ash in the femur bones in both male and female VDR-KO mice. B, DuodenalCa45 incorporation rate in both male and female VDR-KO mice. For both panel A and B: n = 6; The error bars represent standard deviation. **: P value for T-test between wild-type and cod5 group is less than 0.01.

Hind limb bone and duodenal Ca incorporation are important parameters reflecting body Ca uptake levels [25]. Therefore, these results demonstrated that the cod5 diet has higher Ca bioavailability in VDRKO mice. However, the long-term physiological impact of Ca in cod5 diets was unknown. Previous studies show that VDR-KO mice have bone and growth defects that are associated with low Ca absorption. These pathological phenotypes in VDR-KO mice can be partially rescued by high Ca intake [25]. Here we tested whether the removal of oxalate crystals in cod5 could be a sufficient dietary alteration to rescue VDR-KO mice phenotypes. Male VDR-KO mice were divided into five dietary groups (n=10 for 0.5% Ca, 2% Ca and CaOx groups; n=20 for WT and cod5 groups), and the diets were prepared as shown in table 1. A low Ca diet (0.5% Ca) was used as a negative control. A diet that contains 2% CaCl2 was used as positive control. The CaOx diet which contains 2% total Ca but only 0.5% unbound Ca was used as a control to demonstrate that oxalate crystals act as antinutrients for Ca. Both WT and cod5 diets contain 2% total Ca. After 20 days on each diet, the mice fed the 0.5% Ca diet gained an average of 1.75 ± 0.47 g of weight while those fed the 2% Ca diet gained an average of 3.91 ± 0.60 g of weight, showing the effect of increased Ca to rescue growth in these mutant mice. The CaOx diet group gained only 2.14 ± 0.36 g of weight supporting the antinutrient effect of oxalate crystals. The VDR-KO mice fed cod5 diets for 20 days gained 3.37 ± 0.45 g body weight, while the mice in the group fed WT diets gained 2.44 ± 0.54 g of weight. In comparison, the cod5 diets supported 38.1% more body weight gain than the WT diets (P=0.06) (Figure 2).


Figure 2: Weight gain of VDR-KO mice fed with five isocaloric diets containing different calcium sources over 20 days.
0.5% Ca: diet in which the Ca source is the AIN-93G diet base; 2% Ca: diet in which additional CaCl2 was added to AIN-93G to achieve final Ca concentration of 2%; CaOx: diet in which additional CaC2O4 was added to AIN-93G to achieve final Ca concentration of 2%; WT and cod5: diets in which either processed WT or cod5 Medicago was added to AIN-93G to achieve final Ca concentration of 2%. n = 10 for 0.5%, 2% Ca and CaOx group; n = 20 for WT and cod5 group. The error bars represent standard error. a and b represent statistically significantly different groups. P value for T-test between a and b group is less than 0.02 except for WT vs. cod5 group (*: P = 0.06).

The Bone Mineral Density (BMD) is an important indicator for bone health [30]. The VDR-KO mice have lower BMD than C57BL/5 WT mice due to impaired Ca uptake and metabolism [32,33]. BMD was measured at day 1 and day 20 of the dietary regime and the increase of BMD was calculated for mice given each of the five diets (Table 1) groups (n=10). The percentage increase of BMD at day 20 compared to day 1 was calculated for each mice. The 0.5% Ca diet group showed an average of 13.65 ± 1.78% BMD increase while the 2% Ca diet group showed an average of 27.82 ± 1.55% BMD increase. The CaOx diet group had an average of 16.03 ± 1.81% BMD increase. The cod5 diet group showed an average of 20.50 ± 2.98% increase while the WT diet group showed an average of 17.56 ± 2.21% increase in BMD. The cod5 diet supported 16.7% higher BMD increase in VDR-KO mice than WT Medicago diet (P=0.17) (Figure 3).


Figure 3: The percentage increase of bone mineral density (BMD) in VDR-KO mice fed five isocaloric diets containing different calcium sources over 20 days.
0.5% Ca: diet in which the Ca source is the AIN-93G diet base; 2% Ca: diet in which additional CaCl2 was added to AIN-93G to achieve final Ca concentration of 2%; CaOx: diet in which additional CaC2O4 was added to AIN-93G to achieve final Ca concentration of 2%; WT and cod5: diets in which either processed WT or cod5 Medicago was added to AIN-93G to achieve final Ca concentration of 2%. n = 10 for all diet groups. The error bars represent standard error. †: P = 0.17.


While multiple avenues are available to achieve adequate dietary Ca intake, adequate Ca nutrition remains an unresolved nutritional issue [8]. Since the bioavailability of Ca varies greatly among various types of foods, information merely listing the amounts of Ca in foods is misleading [34]. Calcium absorption from plants appears to be inversely proportional to the crystalline oxalic acid content in food [2,14,15,35]. The ability to rapidly identify and characterize gene function and then utilize these genes to engineer plant metabolism has been a driving force in biofortification efforts [36]. The cod5 mutation in Medicago causes removal of crystalline CaOx complexes but unchanged total Ca levels and presents an attractive target for efforts to increase Ca bioavailability.

In our previous work [6], we fed equal number of male and female mice four 45Ca-containing diets: WT M. truncatula extrinsically or intrinsically labeled with 45Ca, and cod5 extrinsically or intrinsically labeled with 45Ca. Extrinsic labeling adds the tracer to the food before ingestion, whereas for intrinsic labeling plants are grown in the presence of the label to incorporate the tracer into the plant matrix. Using both diets, absorption of the tracer was determined one day after consumption. Only in the intrinsically labeled diets, did we note a difference among the diets? We postulate these findings during the formation of crystals in Medicago, much like oxalate crystals in spinach, Ca is bound in a non-bioavailable form. In this study we used only intrinsically labeled foods.

The primarily limitations of using C57BL/6 WT mice is that there is no phenotypes to “rescue” with the modified diets. The level of Ca in cod5 diets, though low, is sufficient to support C57BL/6 mice growth and development so that no obvious phenotypes can be detected. VDR-KO mice have lost the ability to absorb Vitamin D3 -dependent Ca [37]. The VDR-KO mice serum/bone Ca levels are 40% lower than WT mice when fed with 0.5% Ca diets (equivalent to Ca in AIN-76A diets) [37]. Due to this decreased Ca absorption, VDR-KO mice have impaired body growth and bone formation [21]. However, VDR-KO mice have the same serum/bone Ca levels as the WT when fed high Ca diets [37]. Continuous feeding with Ca enriched diets partially rescues the bodyweight and bone formation phenotypes [21]. Utilizing VDRKO mice, here we simultaneously tested Ca bioavailability in cod5 in the hind limbs and duodenum. The phenotypes associated with VDRKO mice disruption are most pronounced in the intestine as this is a key tissue that regulates Ca uptake [30,32]. Our results indicate that the higher levels of bioavailable Ca in cod5 plants lead to increased Ca absorption in duodenum and incorporation in hind limbs in VDRKO mice. Moreover, in the 20-day feeding study, our results showed that cod5 was able to provide more bioavailable Ca to VDR-KO mice than WT Medicago and support bone mass and body weight gain in a similar manner to diets supplemented with exogenous Ca. Overall, our results further support the hypothesis that single gene alterations in CaOx formation in plants can boost Ca bioavailability.

Previous work with C57BL/6 mice has noted sex differences in bone formation. This may indicate a sex-based difference in preserving structural properties of the skeleton [38]. In our feeding study, we also detected male VDR-KO mice were more sensitive to Ca uptake and this might be a result of the male mice’s need for more Ca to support its higher bodyweight than females (Data not shown). However, both male and female VDR-KO mice fed cod5 demonstrated better Ca uptake and bone health and the benefits of the cod5 diets in VDR-KO mice is not gender specific (Figure 1). Our test groups were relatively small and we noted substantial individual variability in feeding behaviors that likely resulted in P value being higher than 0.05. The P value for the long term bodyweight and BMD tests were P=0.06 and P=0.17 respectively. These values would have been smaller than 0.01. However, one VDRKO mouse fed the cod5 diet did not consume the food during the test period and the animal’s bodyweight and BMD didn’t increase (data not shown). Thus, while are results are not statistically significant, the trend is apparent. Large quantities of plant material for the longterm feedings were required and plant rearing space was an issue. In order to provide the diets for 20 days we compromised on the number of animals analyzed. Nonetheless, our data demonstrate a difference between cod5 and WT Medicago lines (Figure 2).

Disruption of one allele of the VDR-KO gene has been shown to impact bone development and impart metabolic consequences [39]. VDR heterozgyous mutant (VDR HET) male mice have normal skeletal development until 16 weeks of age but show significantly less gain in fat mass than WT mice. In contrast, female VDR HET mice show decreased total-body BMD at 8 weeks. In the future, studies using cod5 diets in the VDR HET mice may be informative.

Using foods to attenuate genetic disorders is not a novel concept. Several genetic diseases have been linked to altered mineral nutrition and can be attenuated by dietary therapies. For example, Mitral valve prolapse syndrome (MVP) is a frequent disorder characterized by a number of complaints that lessen the quality of life. Many patients with MVP have low serum magnesium, and supplementation of this ion leads to improvement in most symptoms [40]. However, using modified foods to suppress genetic disorders is an exciting prospect that will require further testing.

If Ca levels are low, Ca supplements may be prescribed to ameliorate phenotypes. Sometimes, Ca based phosphorus binders are prescribed to treat both low Ca and high phosphorus levels. Our work here suggests that foods high in Ca but low in CaOx may also be used as a dietary regime to help patients with chronically low Ca levels.

The low Ca bioavailability in common plant food sources makes it difficult for most vegetarians to meet their Ca intake demands. The work performed with Medicago can serve as a guide for biofortification effort in food plants. Based on our findings, we can predict the benefits in removing oxalate in other common vegetables such as spinach. Currently, work is undergoing to determine the genetic lesion in the cod5 lines. Once the COD5 gene is cloned and characterized, work can be undertaken to modify the COD5 homologs in spinach and other vegetables [17].


Our results further confirm that cod5 Medicago has increased Ca bioavailability compared to WT Medicago. In a long term feeding regime, removal of oxalate from the plant matrix increased absorbed Ca and deposited bone Ca in the consuming animal, thus conveying the idea that genetic changes in food crops can help attenuate effects in genetically susceptible individuals. Our study supports the concept of decreasing antinutrients in crops as an exciting strategy for long-term biofortification strategies to improve nutrient intake.


We thank Tracy Punshon for editing portions of the manuscript. Funding for this work came from the Fundamental Research Funds for the Central Universities, lzujbky-2011-32 to X. Li and the U.S. Department of Agriculture/Agricultural Research Service (under cooperative agreement 58-62650-6001), and the U.S. Department of Agriculture Grant CSRESS#2005-34402-16401 Designing Foods for Health to KDH and to PAN by the U.S. Department of Agriculture/Agricultural Research Service (under cooperative agreement 58-6250-0-008).


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • International Conference And Exhibition on Drug Safety & Pharmacovigilance
    August 29-30, 2018 Toronto, Canada
  • 6th European Biopharma Congress
    September 18-19, 2018 Amsterdam, Netherlands
  • 18th World Pharma Congress
    October 18-20, 2018 Warsaw, Poland

Article Usage

  • Total views: 11844
  • [From(publication date):
    January-2013 - Jul 17, 2018]
  • Breakdown by view type
  • HTML page views : 8071
  • PDF downloads : 3773

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

+1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

nutritionjournals[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version